Gynecomastia in Men: The Estrogen Connection and What Actually Causes It
True gynecomastia is glandular tissue driven by the estrogen-testosterone balance, not just chest fat. What actually causes it, how it’s evaluated, and an honest account of what hormonal care and surgery each can do.
Gynecomastia, the enlargement of male breast tissue, affects a large number of men at some point in their lives, and it is a source of real distress and self-consciousness. Yet it is widely misunderstood. Many men assume it is simply a matter of excess weight or something to be embarrassed about in silence, when in fact true gynecomastia is a specific condition with identifiable causes, often rooted in hormonal balance, that deserves proper understanding and evaluation. Understanding what actually causes gynecomastia, and particularly the role of the balance between estrogen and testosterone, is the foundation for addressing it sensibly.
This article explains what gynecomastia actually is, the crucial distinction between true gynecomastia and what merely looks like it, the hormonal balance at the heart of the condition, the range of causes, and how it is evaluated and approached. If you are a man dealing with gynecomastia and want an honest, complete understanding, this is written for you.
As always, this is educational information rather than individual medical advice, and gynecomastia should be evaluated by a physician who can assess your specific situation.
What gynecomastia actually is
Gynecomastia refers specifically to the enlargement of the glandular breast tissue in men. Men have breast tissue, and under certain hormonal conditions this tissue can grow, producing the enlargement that characterizes gynecomastia. The key word is glandular, because true gynecomastia involves the growth of actual breast gland tissue, as distinct from simply having fat in the chest area, a distinction we return to because it matters enormously for understanding and addressing the condition.
Gynecomastia can affect one or both sides, can vary in degree from mild to pronounced, and can occur at different life stages. It is common during certain periods of life when hormones are shifting, including infancy, puberty, and older age, and it can also occur at other times due to various causes. In many cases that occur during puberty, it resolves on its own as hormones settle, but in other cases it persists or develops later and does not resolve without attention.
The enlargement of breast tissue in gynecomastia is fundamentally driven by hormonal factors, specifically the balance between estrogen and testosterone, which is the central theme for understanding the condition. This is why gynecomastia is, at its root, often a hormonal matter, and why understanding the estrogen-testosterone balance is key.
The crucial distinction: true gynecomastia vs. pseudogynecomastia
Before going further, there is a distinction that is essential to understanding gynecomastia and that causes enormous confusion when it is not understood: the difference between true gynecomastia and what is sometimes called pseudogynecomastia.
True gynecomastia, as described above, involves the growth of actual glandular breast tissue, driven by hormonal factors. Pseudogynecomastia, by contrast, refers to the appearance of enlarged breasts that is actually due to excess fat in the chest area rather than growth of glandular tissue. The two can look similar from the outside, but they are fundamentally different: one is glandular tissue growth driven by hormones, the other is fat accumulation.
This distinction matters enormously because the two have different causes and different approaches. Pseudogynecomastia, being fat, is addressed through the approaches that address body fat generally, including the fundamentals of nutrition, physical activity, and overall fat loss. True gynecomastia, being glandular tissue driven by hormonal factors, is a different matter that involves understanding and addressing the hormonal picture and, in established cases, may involve other approaches as discussed below. Confusing the two leads to frustration, as a man with true glandular gynecomastia who assumes it is just fat may find that fat-loss efforts do not resolve the glandular tissue, while a man with pseudogynecomastia may benefit most from addressing body fat.
Proper evaluation distinguishes between true gynecomastia and pseudogynecomastia, which is a necessary first step in understanding what is actually going on and how to approach it. In some men, both can coexist. Understanding which is present, or whether both are, is foundational.
The estrogen-testosterone balance at the heart of it
The central hormonal factor in true gynecomastia is the balance between estrogen and testosterone, and understanding this balance explains most of what drives the condition.
Both men and women produce both estrogen and testosterone, in different amounts. In men, testosterone predominates, but men do produce and need some estrogen, and the balance between the two matters. Estrogen stimulates breast tissue, while testosterone opposes this effect. When the balance shifts toward relatively more estrogen activity and relatively less testosterone activity, breast tissue can be stimulated to grow, producing gynecomastia. So gynecomastia often reflects a shift in this balance, either relatively too much estrogen, relatively too little testosterone, or both.
A key piece of this is how testosterone and estrogen relate in the male body. Testosterone can be converted into estrogen through a process called aromatization, which occurs particularly in fat tissue. This is one reason the hormonal and body-fat pictures are connected, and it explains several of the causes discussed below. We discuss the roles of estrogen and testosterone, and this conversion, in our article on the difference between estrogen, progesterone, and testosterone and in the context of men’s hormonal health in our discussion of the labs to run for testosterone, which includes estradiol, the main form of estrogen measured in men.
Understanding that gynecomastia often reflects a shift in the estrogen-testosterone balance is the key to understanding its causes, because the various causes largely work by shifting this balance in one way or another.
The causes of gynecomastia
With the estrogen-testosterone balance in mind, the causes of gynecomastia become easier to understand, because most of them work by affecting this balance.
Natural hormonal shifts at certain life stages are a common cause. During puberty, hormonal fluctuations can temporarily shift the balance and produce gynecomastia that often resolves as hormones settle. In older age, testosterone tends to decline while the balance can shift toward relatively more estrogen activity, which is one reason gynecomastia can develop later in life.
Excess body fat is an important and common contributor, through the aromatization described above. Fat tissue converts testosterone into estrogen, so excess body fat can shift the balance toward more estrogen and less testosterone, contributing to gynecomastia. This is also part of why the true gynecomastia and pseudogynecomastia pictures can overlap in men with excess weight: excess fat both creates the fatty chest appearance and, through aromatization, can contribute to actual glandular tissue growth. Addressing excess body fat is therefore relevant to the hormonal picture as well as the appearance.
Low testosterone can contribute, because when testosterone is low, its opposition to estrogen’s effect on breast tissue is reduced, shifting the balance. The hormonal conditions that involve low testosterone can thus be associated with gynecomastia, which is one reason evaluation of testosterone is part of assessing gynecomastia.
Various medications can cause gynecomastia as a side effect, through various effects on the hormonal balance. A range of medications are known to be associated with gynecomastia, which is why a review of medications is part of evaluation. Certain substances, including some recreational ones and alcohol, can also contribute.
Certain medical conditions can cause gynecomastia through their effects on hormones, including conditions affecting the glands that regulate hormones and other conditions. While less common, these are part of what a thorough evaluation considers, because identifying an underlying condition matters both for the gynecomastia and for health generally.
Because the causes are varied and largely work through the hormonal balance, proper evaluation to identify the contributing factors in the individual is the foundation of understanding and addressing gynecomastia.
How gynecomastia is evaluated
Given the range of causes and the importance of the true-versus-pseudogynecomastia distinction, proper evaluation is the essential foundation for addressing gynecomastia sensibly.
Evaluation begins with distinguishing true gynecomastia from pseudogynecomastia, determining whether the enlargement involves glandular tissue, fat, or both, which shapes the entire approach. It includes a hormonal assessment, examining testosterone, estradiol, and related hormones to understand the estrogen-testosterone balance and whether a hormonal shift is contributing. It includes a review of medications and substances that could be contributing. And it considers whether an underlying condition might be involved, particularly in cases that are pronounced, occur without an obvious cause, or have other concerning features.
This evaluation identifies what is actually driving the gynecomastia in the individual, which is what allows a sensible, appropriate approach rather than guesswork. Our advanced labs service provides the comprehensive hormonal assessment that is part of evaluating gynecomastia, and our men’s hormone health service addresses the hormonal picture in context.
How gynecomastia is approached
How gynecomastia is approached depends on what evaluation reveals, and honesty requires being clear about what the different approaches can and cannot do.
For pseudogynecomastia, where the issue is excess fat rather than glandular tissue, addressing body fat through the fundamentals of nutrition, physical activity, and overall fat loss is the relevant approach, since the issue is fat.
For true gynecomastia, the approach depends on the cause and the stage. When a contributing factor is identified, addressing it is appropriate: if a medication is the cause, reviewing it with the prescribing physician; if excess body fat is contributing through aromatization, addressing body fat; if low testosterone or a hormonal imbalance is involved, addressing the hormonal picture through appropriate medical care. Addressing the underlying hormonal contributors, including the estrogen-testosterone balance, is relevant particularly in earlier stages and where a clear contributing factor is found.
It is important to be honest about the limits here. Addressing hormonal contributors is relevant to the underlying factors, but established, longstanding glandular gynecomastia does not always resolve simply by addressing hormones, because once glandular tissue has developed and matured, it may persist even after the hormonal contributors are addressed. In such established cases, surgical removal of the glandular tissue is often the definitive approach, and it is the option that reliably addresses established glandular tissue. We do not claim that hormonal optimization or any medication reverses established gynecomastia; what hormonal evaluation and care can do is identify and address contributing factors, which is most relevant in earlier stages and for preventing progression, while surgery remains the definitive option for established glandular tissue. This honest framing is important, because overstating what hormonal approaches can do for established gynecomastia would set false expectations.
The sensible approach, then, is proper evaluation to understand what is driving the gynecomastia and whether it is glandular or fat, followed by addressing the identified contributors through the appropriate means, with realistic understanding of what each approach can accomplish and with surgery recognized as the definitive option for established glandular tissue. A provider can guide this based on the individual’s evaluation.
The Houston context
The Tide is a medical clinic located adjacent to the Texas Medical Center, and our approach to the hormonal dimension of gynecomastia reflects our broader commitment to real evaluation and honest care. We evaluate the hormonal picture thoroughly, assessing the estrogen-testosterone balance and the factors that may be contributing, and we help men understand what is actually driving their gynecomastia, including the crucial distinction between glandular tissue and fat. We address the hormonal contributors where appropriate and are honest about what hormonal care can and cannot accomplish, including recognizing when surgery is the definitive option for established glandular tissue.
For Houston men dealing with gynecomastia who want to understand the hormonal factors and have them properly evaluated, a consultation provides thorough assessment and honest guidance about the estrogen connection and what actually drives the condition.
About The Tide
The Tide is a medical clinic in Houston, Texas, located adjacent to the Texas Medical Center. Our men’s hormone health service provides comprehensive hormonal evaluation relevant to gynecomastia, assessing the estrogen-testosterone balance through our advanced labs service and addressing identified hormonal contributors where appropriate. We are honest that hormonal care addresses contributing factors, most relevant in earlier stages, while surgery remains the definitive option for established glandular tissue; we do not claim hormonal optimization reverses established gynecomastia. Every patient begins with comprehensive baseline labs and a provider consultation. For related reading, see our articles on the difference between estrogen, progesterone, and testosterone, the labs to run for testosterone, and why low testosterone might be a simple fix, and our clinical standards.
Related articles.
What Is Metabolic Health? The 5 Markers That Actually Matter
Standard blood-sugar tests miss metabolic problems until they’re advanced. The five markers that reflect metabolic health earlier, including the one routine testing almost always skips: fasting insulin.
Erectile Dysfunction: Testosterone, PT-141, and Why Evaluation Matters
Erectile dysfunction has many causes and can be an early cardiovascular warning sign. The real treatment options, from PDE5 inhibitors and testosterone to PT-141, and why evaluation matters more than a quick pill.
Microdosing GLP-1s: What It Means and What to Know
Microdosing means using lower-than-standard GLP-1 doses. What the term actually means, why people are interested, what the evidence does and doesn’t support, and why it isn’t an FDA-approved protocol.